Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
Jude group used this approach to analyze leukemia samples from 242 pediatric patients with ALL.
Jude研究组就是采用这种方法对242名ALL患儿进行了分析。
应用推荐